)
Edge11 Sep 2026
Texas Pacific Land Corporation: Keeper of the Permian Basin
Land once granted to a failed 19th-century railroad now generates royalties for Texas Pacific Land Corporation across the Permian Basin.
Alterity Therapeutics
Alterity Therapeutics (ATH) investor relations material
Alterity Therapeutics 12th Annual Cantor Fitzgerald Global Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.12th Annual Cantor Fitzgerald Global Healthcare Conference summary11 Sep, 2026
Company and leadership overview
CEO joined in 2017, bringing CNS drug development experience and a U.S. presence to an Australia-based team.
Focus is on developing therapies for multiple system atrophy (MSA), a rapidly progressing, devastating neurodegenerative disease.
Disease background and unmet need
MSA is aggressive, with average survival of 7–8 years and rapid loss of mobility; current therapies are only symptomatic and largely ineffective.
There is a significant need for disease-modifying treatments that can slow progression and improve quality of life.
ATH434 mechanism and clinical rationale
ATH434 is an iron chaperone that redistributes iron within cells, reducing its pathological impact without removing it from the body.
The drug targets iron accumulation, a near-universal feature in MSA, as established by the bioMUSE natural history study.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Alterity Therapeutics
- Net loss increased 93% to A$23.4M as R&D and admin costs rose, but Phase 3 ATH434 trial is on track.ATH
H2 2026 - ATH434 showed robust phase II efficacy in MSA, with phase III and major commercial potential ahead.ATHCanaccord Genuity's 46th Annual Growth Conference
- Regulatory pathway secured for ATH434 in MSA; Phase 3 trial and strong cash position support growth.ATHQ4 2026 TU
- ATH434 demonstrated significant efficacy and safety in MSA, advancing to Phase 3 trials.ATHCorporate presentation
- ATH434 advances toward Phase 3 with strong cash reserves and positive clinical data.ATHQ3 2026 TU
- ATH434 slowed MSA progression by up to 48% in phase II, supporting a pivotal phase III trial in 2026.ATHKOL event
- Net loss widened to A$19.1M as R&D spending rose; cash reserves at A$12.6M, equity raise planned.ATHH2 2024
- ATH434 showed strong Phase 2 efficacy in MSA, narrowing losses and boosting cash reserves.ATHH2 2025
- ATH434 slowed MSA progression in phase II, with global phase III and $2.4B peak sales projected.ATHNWR Virtual Healthcare Conference
Alterity Therapeutics
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage